TC
DVAX

Truvestments Capital’s Dynavax Technologies DVAX Stock Holding History

Truvestments Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-220
Closed -$2.34K – 736
2022
Q4 		$2.34K Hold
220
– – ﹤0.01% 695
2022
Q3 		$2K Hold
220
– – ﹤0.01% 549
2022
Q2 		$3K Buy
+220
New +$2.34K ﹤0.01% 527

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Truvestments Capital's DVAX Position: Q1 2023 in Review

Truvestments Capital sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 220 shares — an estimated $2.34K sold.

Truvestments Capital first reported a position in DVAX in Q2 2022 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • Truvestments Capital reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • Truvestments Capital sold 220 Dynavax Technologies shares in Q1 2023, an estimated $2.34K.
  • Truvestments Capital first reported a position in Dynavax Technologies in Q2 2022 and held it in 3 quarters.
  • Truvestments Capital's Dynavax Technologies position peaked at $3K in Q2 2022.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.